Inflammopharmacology

Journal Title：Inflammopharmacology

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states

-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs

-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents

-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain

-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs

-Muscle-immune interactions during inflammation [...]

Inflammopharmacology 是国际基础与临床药理学联合会 (IUPHAR) 胃肠道分会和匈牙利实验与临床药理学会 (HECPS) 的官方出版物。 Inflammopharmacology 发表了关于炎症及其药理控制的所有方面的论文，强调比较 (a) 不同的炎症状态，以及 (b) 用于治疗炎症的药物的作用、治疗效果和安全性。炎症状况类型的比较方面包括胃肠道疾病（例如溃疡性结肠炎、克罗恩病）、寄生虫病、药物和环境因素作用的毒理学表现、关节炎状况以及损伤或老化对骨骼肌的炎症作用。该期刊有七个主要兴趣领域：

-药物-疾病相互作用-条件药理学-即条件（疾病或压力状态）影响抗炎药的治疗反应和副作用（不利）。药物-疾病和药物疾病相互作用的机制及不同应激状态的作用

-风湿病学 - 特别强调新药临床反应效果、抗风湿药物副作用的测量方法

-胃肠病学 - 特别强调动物和人体模型、粘膜炎症和溃疡的机制以及新型和已确立的抗溃疡、抗炎剂或抗寄生虫剂的作用

-神经炎症和疼痛 - 模型系统、新型镇痛药的药理学和神经炎症和疼痛的机制

-新型药物、天然产品和保健品 - 及其对炎症过程的影响，特别是与传统药物相比，有新模式作用的迹象，例如非甾体抗炎药

-炎症期间的肌肉-免疫相互作用 [...]

Inflammopharmacology创刊于1991年，由SPRINGER BASEL AG出版商出版，收稿方向涵盖IMMUNOLOGYTOXICOLOGY - TOXICOLOGY全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。影响因子指数3.238，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。